263 related articles for article (PubMed ID: 30419807)
1. PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation.
Xie B; Liu X; Yang J; Cheng J; Gu J; Xue S
BMC Cell Biol; 2018 Nov; 19(1):24. PubMed ID: 30419807
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.
Jennewein C; Kuhn AM; Schmidt MV; Meilladec-Jullig V; von Knethen A; Gonzalez FJ; Brüne B
J Immunol; 2008 Oct; 181(8):5646-52. PubMed ID: 18832723
[TBL] [Abstract][Full Text] [Related]
4. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.
Yang N; Liu S; Qin T; Liu X; Watanabe N; Mayo KH; Li J; Li X
Cell Commun Signal; 2019 Nov; 17(1):153. PubMed ID: 31752909
[TBL] [Abstract][Full Text] [Related]
5. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
8. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
[TBL] [Abstract][Full Text] [Related]
9. Roles of the SUMO-related enzymes, PIAS1, PIAS4, and RNF4, in DNA double-strand break repair by homologous recombination.
Han MM; Hirakawa M; Yamauchi M; Matsuda N
Biochem Biophys Res Commun; 2022 Feb; 591():95-101. PubMed ID: 35007836
[TBL] [Abstract][Full Text] [Related]
10. PIAS1 and TIF1γ collaborate to promote SnoN SUMOylation and suppression of epithelial-mesenchymal transition.
Chanda A; Ikeuchi Y; Karve K; Sarkar A; Chandhoke AS; Deng L; Bonni A; Bonni S
Cell Death Differ; 2021 Jan; 28(1):267-282. PubMed ID: 32770107
[TBL] [Abstract][Full Text] [Related]
11. Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility.
Li C; McManus FP; Plutoni C; Pascariu CM; Nelson T; Alberici Delsin LE; Emery G; Thibault P
Nat Commun; 2020 Feb; 11(1):834. PubMed ID: 32047143
[TBL] [Abstract][Full Text] [Related]
12. PIAS1 binds p300 and behaves as a coactivator or corepressor of the transcription factor c-Myb dependent on SUMO-status.
Ledsaak M; Bengtsen M; Molværsmyr AK; Fuglerud BM; Matre V; Eskeland R; Gabrielsen OS
Biochim Biophys Acta; 2016 May; 1859(5):705-18. PubMed ID: 27032383
[TBL] [Abstract][Full Text] [Related]
13. Protein inhibitor of activated STAT1 Ser
Liu SY; Ma YL; Hsu WL; Chiou HY; Lee EHY
Br J Pharmacol; 2019 Jun; 176(11):1793-1810. PubMed ID: 30849179
[TBL] [Abstract][Full Text] [Related]
14. Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer.
Chanda A; Chan A; Deng L; Kornaga EN; Enwere EK; Morris DG; Bonni S
PLoS One; 2017; 12(5):e0177639. PubMed ID: 28493978
[TBL] [Abstract][Full Text] [Related]
15. PIAS1-mediated sumoylation promotes STUbL-dependent proteasomal degradation of the human telomeric protein TRF2.
Her J; Jeong YY; Chung IK
FEBS Lett; 2015 Oct; 589(21):3277-86. PubMed ID: 26450775
[TBL] [Abstract][Full Text] [Related]
16. Leukemogenic kinase FIP1L1-PDGFRA and a small ubiquitin-like modifier E3 ligase, PIAS1, form a positive cross-talk through their enzymatic activities.
Ibata M; Iwasaki J; Fujioka Y; Nakagawa K; Darmanin S; Onozawa M; Hashimoto D; Ohba Y; Hatakeyama S; Teshima T; Kondo T
Cancer Sci; 2017 Feb; 108(2):200-207. PubMed ID: 27960034
[TBL] [Abstract][Full Text] [Related]
17. SUMO E3 ligase PIAS1 is a potential biomarker indicating stress susceptibility.
Lin HY; Liu YS; Huang CY; Cathomas F; Liu K; Wang J; Cheng HT; Lai SW; Liu YC; Chen CJ; Lin C; Lu DY
Psychoneuroendocrinology; 2020 Oct; 120():104800. PubMed ID: 32688147
[TBL] [Abstract][Full Text] [Related]
18. Profiling the Murine SUMO Proteome in Response to Cardiac Ischemia and Reperfusion Injury.
Hotz PW; Wiesnet M; Tascher G; Braun T; Müller S; Mendler L
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260959
[TBL] [Abstract][Full Text] [Related]
19. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
[TBL] [Abstract][Full Text] [Related]
20. PIAS1 Alleviates Hepatic Ischemia-Reperfusion Injury in Mice through a Mechanism Involving NFATc1 SUMOylation.
Luo J; Li J; Li T; Zhang Z; Chen G; Li Q; Qi H; Si Z
Dis Markers; 2022; 2022():4988539. PubMed ID: 36092961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
